AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 18, 2016
5262_dirs_2016-07-18_8445a1fe-2725-418f-873a-9d3d2d872e59.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 5066E
GlaxoSmithKline PLC
18 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr R G Connor
b)
Position/status
President, Global Manufacturing & Supply
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £16.6781 | 30.955 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-07-14
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZVLFFQDFEBBL
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'36VycS5yPru8fbRcmA4ZDRQNYFCTL3_9iyTbyCa8N4E8Wmtf-ULWf-svzbIWbSZl2dw-BHJDDXjCpL3_U8VirqrXxCgwtEvzXvXSGzgd1KM1:7MMWyYGLMm_dfQD-jtGgpVr-NrFcs7T23pMajGFTi2-BF3S639dqof1m4xDoVP-POM8Rnco-rZmcHDfhxhTY5BCZDuERzfIzJ0olzbthJbk1'}});//]]>